Statements of Cash Flows (USD $)	3 Months Ended		100 Months Ended
	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2013
Cash Flows Provided (Used) By Operating Activities
Net loss	$ (1,713,833)	$ (857,314)	$ (36,564,228)
Adjustments to reconcile net loss to net cash used by operating activities:
Amortization	419	343	4,689
Issuance of common stock for services	110,668	546,821	18,573,848
Issuance of common stock as deferred financing costs			13,500
Stock based compensation from issuance of options	1,080,201	27,174	7,993,323
Stock based compensation from issuance of warrants			3,422,700
Accreted interest on debt discounts	132,428	102,609	613,193
Change in derivative	48,713	(21,152)	(109,320)
Changes in assets and liabilities:
(Increase) in prepaid insurance	8,500		(12,750)
Increase (decrease) in accounts payable	(16,424)	3,272	24,343
Increase in accrued salaries and wages	74,414	(7,500)	532,050
Net cash used by operating activities	(274,914)	(205,747)	(5,508,652)
Cash Flows Provided (Used) By Investing Activities
Cash Flows Provided (Used) By Financing Activities
Borrowings from related parties			922,587
Borrowings on convertible notes payable		187,500	604,500
Payments to related parties on notes payable			(436,175)
Investment received in exchange for royalty agreement			750,000
Issuance of common stock for cash			3,991,449
Net cash provided from financing activities		187,500	5,832,361
Net increase (decrease) in cash and cash equivalents	(274,914)	(18,247)	323,709
Cash and cash equivalents, beginning of period	598,623	20,423
Cash and cash equivalents, end of period	323,709	2,176	323,709
Supplemental disclosure
Interest paid during the period	125,547	6,726	390,027
Taxes paid during the period
Non-Cash Transactions
Conversion of debt to equity		25,000	370,844
Debt discounts attributable to derivative valuation	132,428		452,205
Settlement of derivative liability	8,820		8,820
Cashless exercise of warrants	1,524		1,524
Derivative liability	$ 337,413		$ 337,413